ArticleRespiratory medicine case reports2023
Pulmonary cryptococcus (case series, Regional VIC, Australia).
Article in Respiratory medicine case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and objectives: Cryptococcus is a fungal pathogen, epidemiologically dominant in tropical and subtropical areas of Australia. With this clinical case report, we aim to acknowledge the incidence of pathogen in Victoria and solidify clinicians to in considering as a differential diagnosis with its different nature of presentations. Materials and methods: We identified five cases of pulmonary cryptococcus over a period of 10 months at Monash Medical Centre, Clayton, Victoria. Cases were retrospectively reviewed from onset of presentations through diagnosis and management. Identities and personal information of patients remained anonymous. Consents were obtained via electronic medical documentation. Results: In this case study, only one patient was immunosuppressed while others were immunocompetent. Number of cryptococcus gatti and neoformans was equally distributed in immunocompetent patients, while immunosuppressed patient had C.neoformans. Four out of five patients had respiratory symptoms and remaining patient (immunocompetent) had neurological complication despite absence of respiratory symptoms. As of radiological features, cavitating lesion was observed in immunosuppressed patient, while in immunocompetent ones, two had nodular feature, one had cavitating and other had endobronchial soft tissue density. Three patients achieved diagnosis confirmation by bronchial washings + BAL while two achieved by biopsy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.